Issuer Information

EDGAR: Contact Information
  • Name:
    Trevi Therapeutics, Inc.
  • Address:
    195 CHURCH STREET
    14TH FLOOR
    NEW HAVEN, CONNECTICUT 06510
  • Phone:
    203-304-2499
EDGAR: Other Information
  • Jurisdiction:
    DELAWARE
  • Entity Type:
    Corporation
  • Incorporated:
    Over 5 years ago
  • Previous Names:
    None

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
440825: 0001563880-22-000001
First Sale: 2022-04-11
Security Type(s): Equity
Offer Amount: $54,999,998
Amount Sold: $54,999,998
06b No Notices in EFD for this offering.
404679: 0001563880-21-000003
First Sale: 2021-10-18
Security Type(s): Equity
Offer Amount: $3,000,000
Amount Sold: $3,000,000
06b No Notices in EFD for this offering.
404405: 0001563880-21-000001
First Sale: 2021-10-05
Security Type(s): Equity
Offer Amount: $11,819,891
Amount Sold: $11,819,891
06b No Notices in EFD for this offering.
243096: 0001563880-18-000002
First Sale: 2017-07-14
Security Type(s): Equity
Offer Amount: $61,906,460
Amount Sold: $51,906,460
Remaining: $10,000,000
06b No Notices in EFD for this offering.
66415: 0001563880-12-000001
First Sale: 2012-12-05
Security Type(s): Equity
Offer Amount: $13,064,102
Amount Sold: $6,564,102
Remaining: $6,500,000
06 No Notices in EFD for this offering.

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.